聚焦制药服务报告:寻找地板(英)-2026。We are bullish on clinical services and outsourcing for the end of 2026 and into 2027. The biopharma VC rebound and the growth of AI-enabled drug discovery are both filling early-stage pipelines, which should translate into stronger demand for CROs and CDMOs over the next two to four quarters.
聚焦制药服务报告:寻找地板(英)-2026。We are bullish on clinical services and outsourcing for the end of 2026 and into 2027. The biopharma VC rebound and the growth of AI-enabled drug discovery are both filling early-stage pipelines, which should translate into stronger demand for CROs and CDMOs over the next two to four quarters.
聚焦制药服务报告:寻找地板(英)-2026。We are bullish on clinical services and outsourcing for the end of 2026 and into 2027. The biopharma VC rebound and the growth of AI-enabled drug discovery are both filling early-stage pipelines, which should translate into stronger demand for CROs and CDMOs over the next two to four quarters.
本报告由PitchBook发布,发布于 2026 年。
覆盖 2026 年,全文共 9 页。
本报告为付费报告,可在资料宝站内下单后获取完整内容。
重点分析了制药、制药服务报告、寻找地板等议题。